logo

For the Inventor, By the Inventor

Espoo, Finland

Orion Corporation


USPTO Granted Patents = 189

% Expired Patents = 13.8



Trademarks = 48

Forward Citations = 1,622

Loading Chart...
Loading Chart...

319 inventors (with patents filed for the assignee):

goldMedal Gerd Wohlfahrt (17 out of 17 patents)

silverMedal Arja Karjalainen (13 out of 13 patents)

bronzeMedal Olli Törmäkangas (12 out of 13 patents)

4.  Hwa-kyung Lee (12 out of 14 patents)

5.  David Din Belle (10 out of 10 patents)

6.  Jouko Levijoki (10 out of 10 patents)

7.  Arto J Karjalainen (10 out of 39 patents)

8.  Sock Woo Lee (10 out of 10 patents)

9.  Patrik Holm (9 out of 9 patents)

10.  Petteri Rummakko (9 out of 15 patents)

11.  Jarmo J Pystynen (9 out of 20 patents)

12.  Pekka Pietikäinen (8 out of 8 patents)

13.  Eija Tiainen (8 out of 8 patents)

14.  Heimo O Haikala (8 out of 16 patents)

15.  Eun Je Choe (8 out of 8 patents)


Core Competencies:
Pharmaceutical Composition
Snack Packaging
Inhaler
Androgen Receptor Modulators
CYP11A1 Inhibitors
Veterinary Methods
Protein Kinase Inhibitors
Carboxamide Derivatives
Bromodomain Inhibitors
Levodopa
Pregabalin Formulations
Hydrodynamic Bearings

189 patents:

1. 12747207 - TEAD inhibitors (2026-09-29),
2. 12735408 - 2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)(5-(phenyl)-pyridin-3-yl)methanone derivatives and similar compounds as CYP11A1 inhibitors for the treatment of prostate cancer (2026-09-15),
3. D1141940 - PACKAGING (2026-08-18),
4. D1124889 - Packaging (2026-05-05),
5. 12611397 - Pharmaceutical composition of darolutamide (2026-04-28),
6. 12583840 - Method for the preparation of androgen receptor antagonists and intermediates thereof (2026-03-24),
7. D1116808 - Packaging box (2026-03-10),
8. 12558331 - Pregabalin formulations and use thereof (2026-02-24),
9. D1108977 - Packaging (2026-01-13),
10. 12521363 - Use of levodopa, carbidopa and entacapone for treating Parkinson's disease (2026-01-13),
11. D1096400 - Packaging (2025-10-07),
12. D1096399 - Packaging (2025-10-07),
13. D1085870 - Packaging (2025-07-29),
14. D1083618 - Packaging (2025-07-15),
15. 12329742 - Pharmaceutical composition of darolutamide (2025-06-17),
Orion Corporation, headquartered in Espoo, Finland, is a prominent player in the pharmaceutical packaging sector. The company specializes in developing and manufacturing innovative solutions for pharmaceutical compositions, including inhalers and veterinary methods. Orion's research focuses on advanced therapeutic areas such as androgen receptor modulators, CYP11A1 inhibitors, and protein kinase inhibitors, alongside snack packaging technologies. With a commitment to enhancing healthcare and patient outcomes, Orion continues to drive advancements in its core technology domains.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Orion Corporation
189 Patents

#11 in Espoo

#25 in Finland

#4,449 in the World

Espoo, FI
Espoo, Finland

Orion Corporation

Forward Citations = 1,622

319 inventors:

goldMedal Gerd Wohlfahrt (17 out of 17 patents)

silverMedal Arja Karjalainen (13 out of 13 patents)

bronzeMedal Olli Törmäkangas (12 out of 13 patents)

4.  Hwa-kyung Lee (12 out of 14 patents)

5.  David Din Belle (10 out of 10 patents)

Please report any incorrect information to [email protected]
Loading…